Abstract
Overexpression of P-glycoprotein (P-gp) has been implicated as the mechanism of multidrug resistance (MDR) in a number of human cancers, including carcinoma of the breast. We conducted a clinical trial to determine whether the P-gp inhibitor, trifluoperazine, could sensitize patients with refractory breast cancer to vinblastine chemotherapy. Adult patients with histologically confirmed, refractory, advanced breast cancer were treated with vinblastine at a dose of 1.7 mg/m2 per day by continuous infusion for five consecutive days. Patients who did not respond after two cycles were subsequently treated with vinblastine plus trifluoperazine at a dose of 8 mg twice daily during the five days of chemotherapy. In patients from whom tumor samples were available, the expression of P-gp was determined by immunocytochemistry. Of 35 patients enrolled, 30 were evaluable, 2 of whom (7%) achieved a partial response to vinblastine alone. Among the 16 patients treated with vinblastine plus trifluoperazine there was one response (6%) which lasted 16 weeks. Tumor samples were available from 16 patients, and 14 (87%) were immunoreactive for P-pg. P_pg expression was detected both in the patient who responded to vinblastine plus trifluoperazine an...Continue Reading
Citations
Sep 24, 2008·Applied Microbiology and Biotechnology·Xiuping LinJilun Li
Oct 28, 2005·Journal of Neural Transmission·U SchmittS Härtter
Mar 5, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Andrzej PołaMasami Kawase
Aug 12, 1998·Obstetrics and Gynecology·A K Sood, R E Buller
Oct 30, 1998·Critical Reviews in Oncology/hematology·M ClynesK Scanlon
Jul 27, 2011·PloS One·Lei HuangYang Dai
Jun 5, 2003·Expert Opinion on Investigational Drugs·Rita NahtaFrancisco J Esteva
Jul 5, 2005·Expert Opinion on Investigational Drugs·J Robert
Dec 20, 2005·Seminars in Oncology·William N Hait, Jin-Ming Yang
Aug 30, 2001·Hematology/oncology Clinics of North America·R S DiPaolaM M Rafi
Nov 19, 2013·Biochemical Pharmacology·Fei ZhangRuifang Niu
Apr 3, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Laleh Amiri-KordestaniSusan E Bates
Jun 7, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Joyce C de MelloTiago Rodrigues
Jul 3, 2019·International Journal of Molecular Sciences·Kuan-Lin KuoKuo-How Huang
Mar 20, 2019·Cancers·Philippe KischelHalima Ouadid-Ahidouch
May 16, 2017·The Journal of Clinical Investigation·Jaya SangodkarGoutham Narla
Mar 7, 2019·Frontiers in Pharmacology·Jun MaPenggao Dai
May 16, 2019·Cellular and Molecular Life Sciences : CMLS·Winnie Fong, Kenneth K W To
Sep 22, 2020·Brain Communications·Joni MerisaariJukka Westermarck
Jan 8, 2017·Molecular Cancer Therapeutics·Seokmin KangSang Soo Kang
Aug 3, 2005·Cancer Research·Karl E Miletti-GonzálezLorna Rodríguez-Rodríguez
Jan 24, 2018·Cancer Research·Kimberly McClinchMatthew D Galsky
Apr 30, 2019·American Journal of Therapeutics·Marissa B SerafinRosmari Hörner
Oct 31, 2003·Journal of Medicinal Chemistry·Jacques Robert, Christian Jarry